Institutional ownership · Form 13F
CVS institutional ownership
CVS Health: reported institutional holdings as of 2026-06-30 (filed through 2026-08-31), aggregated by StockEyes from SEC Form 13F information tables. CVS is one of 2732 tickers in the validated publication set. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.
CVS: change since the prior quarter's filings
More managers reported a position, with the count rising from 1,849 in the quarter ended 2026-03-31 to 2,064 in the quarter ended 2026-06-30 (+215, 11.6%). Total reported shares rose to 1,140,609,707 (+41,476,650, 3.8%), moving the same way as the manager count. Among the 27 managers listed as top holders in both quarters, the largest increases were BANK OF AMERICA CORP /DE/ (+13,836,701 shares) and WELLINGTON MANAGEMENT GROUP LLP (+11,233,381 shares), among 10 managers who added shares, and the largest decreases were JPMORGAN CHASE & CO (-7,414,155 shares) and Invesco Ltd. (-4,543,515 shares), among 17 managers who reduced shares. NORGES BANK (18,038,922 shares), FRANKLIN RESOURCES INC (9,985,330 shares) and 1 more entered the listed top holders; GLENVIEW CAPITAL MANAGEMENT, LLC (8,196,799 shares in the prior quarter), WELLS FARGO & COMPANY/MN (8,111,035 shares in the prior quarter) and 1 more dropped out of the listed top holders.
New to 13F data? Read how to read a 13F filing, or see where institutions moved overall in the Smart Money Report.
Reported totals, quarter ended 2026-06-30
2,064 reporting managers held 1,140,609,707 shares, reported value $112,763,662,182 exactly as filed. Values are position values transcribed from the filings, not current market prices.
Reported quarter-over-quarter change (quarter ended 2026-03-31 to quarter ended 2026-06-30): reporting managers +215, reported shares +41,476,650 (+3.77%), reported value +49.09%. These changes compare two filing snapshots.
Shares outstanding check: 1,279,000,000 shares reported by the issuer (SEC XBRL, period ended 2026-06-30). Reported 13F shares equal 89.2% of that figure. This page passed the publication sanity gate before listing.
CVS in this quarter's filings
Concentration check: the largest reported position, BlackRock, Inc. with 123,223,409 shares, is 10.8% of all shares reported for CVS this quarter. The five largest reporting managers together account for 34.3% of the reported total, so the headline total is spread across a broad manager base rather than a few holders.
Reported quarter-over-quarter change: the reporting-manager count rose by 215 versus the quarter ended 2026-03-31, and reported shares moved +3.77% (+41,476,650 shares). That is a comparison of two filing snapshots, not a record of trades on any single day.
Shares-outstanding cross-check: reported 13F shares equal 89.2% of the issuer share count used at the publication gate (1,279,000,000 shares, issuer period ended 2026-06-30). The gate publishes a ticker only when that relationship is plausible; lending chains can push reported totals above a simple ownership share, which is why the figure is a sanity check and not an ownership percentage.
Largest reporting managers, CVS
| # | Manager | Shares | Value as filed | Share of reported total |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 123,223,409 | $12,747,461,705 | 10.8% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 83,315,369 | $8,618,974,924 | 7.3% |
| 3 | Capital World Investors | 74,951,955 | $7,753,834,783 | 6.6% |
| 4 | STATE STREET CORP | 60,283,408 | $6,236,318,558 | 5.3% |
| 5 | Dodge & Cox | 50,012,765 | $5,173,820,539 | 4.4% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 33,801,113 | $3,496,725,140 | 3.0% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 29,899,653 | $3,079,404,427 | 2.6% |
| 8 | FMR LLC | 28,920,617 | $2,991,837,927 | 2.5% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 26,637,259 | $2,755,624,444 | 2.3% |
| 10 | Capital Research Global Investors | 24,329,151 | $2,516,851,376 | 2.1% |
| 11 | BANK OF AMERICA CORP /DE/ | 23,188,670 | $2,398,868,007 | 2.0% |
| 12 | JPMORGAN CHASE & CO | 22,112,970 | $2,290,461,677 | 1.9% |
| 13 | Invesco Ltd. | 20,595,431 | $2,130,597,379 | 1.8% |
| 14 | MORGAN STANLEY | 18,606,028 | $1,924,793,937 | 1.6% |
| 15 | NORGES BANK | 18,038,922 | $1,866,126,481 | 1.6% |
Manager names and figures are transcribed from each manager's own Form 13F information table. A manager listing shares in this snapshot does not mean it holds them today.
Reported change, 2026-03-31 to 2026-06-30
| Quarter ended | Filed through | Reporting managers | Reported shares | Value as filed |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-29 | 1,849 | 1,099,133,057 | $75,632,896,659 |
| 2026-06-30 | 2026-08-31 | 2,064 | 1,140,609,707 | $112,763,662,182 |
Every change figure on this page is a reported quarter-over-quarter change between filing snapshots. It is not real-time trading activity.
CVS reported totals over time
Quarter ended 2026-06-30: 2,064 reporting managers · 1,140,609,707 reported shares · $112,763,662,182 value as filed.
The full archived series is part of StockEyes Pro. Continue with Google to sign in.
Quarter-end 13F filed data, long positions only; filings arrive up to 45 days after quarter end.
CUSIPs behind the CVS total
The validated bridge mapped 1 current CUSIP(s) to CVS for this quarter: 126650100. Option pseudo-CUSIPs, units, warrants, and preferred classes are excluded from these common-share totals. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.
What this page is and is not
Form 13F reports are quarterly holdings snapshots. Managers file up to about 45 days after quarter-end, so these figures describe reported positions as of the quarter-end date, not holdings today. 13F lists reportable long positions from managers above the SEC reporting threshold and omits short positions entirely.
This page is informational only. It is not investment advice, a recommendation, or a signal to buy or sell. Source: SEC Form 13F bulk data set for filings through 2026-08-31 (period ended 2026-06-30), joined to tickers through StockEyes' validated CUSIP bridge. Methodology and coverage are documented on the institutional ownership hub.
Insider transactions for CVS (officer and director buys and sells) are covered by InsiderTrace: insidertrace.com/stock/cvs. StockEyes does not duplicate insider transaction tables.
Related StockEyes pages
Latest headlines tagged CVS are on the market news wire. Upcoming earnings and market dates are on the events calendar. The term itself is defined in the institutional investor glossary entry, and the research workflow behind pages like this one is walked through in how to research a stock and how to compare SEC filings.